AtonRa Partners

SEC CIK: 0001846445
Latest filing: Feb 5, 2024

SEC filings (opens in a new tab)

CBAY holding history

CymaBay Therapeutics, Inc. in every 13F filed by AtonRa Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CBAY overview All 13F holders of CBAY Full Q4 2023 holdings

Shares (Q2 2021): 0; Sold out in Q2 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 1; Since Q1 2021

Holdings of CBAY by AtonRa Partners, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2021	0	$0	0.0%	−111,525−100.0%	Sold out	Holders
Q1 2021	111,525	$506.0K	0.2%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.